期刊文献+

卵巢癌患者肿瘤细胞减灭术后复发的影响因素 被引量:4

Influencing factors of recurrence after cytoreductive surgery in patients with ovarian cancer
下载PDF
导出
摘要 目的分析卵巢癌(OC)患者肿瘤细胞减灭术(CRS)后复发的影响因素。方法回顾性收集107例OC患者的资料,所有患者均完成CRS治疗,并随访2年。根据术后2年内肿瘤复发情况将患者分为复发组和未复发组。采用Logistic回归分析探讨导致OC患者CRS术后复发的影响因素。结果107例OC患者中,CRS术后68例复发,复发率为63.55%;复发组患者乳腺癌易感基因-1(BRCA-1)、聚腺苷二磷酸核糖聚合酶-1(PARP-1)表达、残瘤直径、术中淋巴结清扫、糖类抗原125(CA125)水平、人附睾分泌蛋白4(HE4)水平与未复发组比较,差异有统计学意义(P<0.05);复发组和未复发组OC患者的年龄、肿瘤直径、国际妇产科联合会(FIGO)分期、组织分型、产次、术前绝经、淋巴结转移、不同分化程度肿瘤细胞占比、血清糖类抗原199(CA199)、癌胚抗原(CEA)比较,差异无统计学意义(P>0.05)。Logistic回归分析结果显示,BRCA-1阳性表达、PARP-1阳性表达、残瘤直径>1 cm、术中未清扫淋巴结、CA125水平升高、HE4水平升高可能是OC患者CRS术后复发的危险因素(OR>1,P<0.05)。结论BRCA-1阳性表达、PARP-1阳性表达、残瘤直径>1 cm、术中未清扫淋巴结、CA125水平升高、HE4水平升高可能是OC患者CRS术后复发的危险因素。 Objective To analyze the influencing factors of recurrence after cytoreductive surgery(CRS) in patients with ovarian cancer(OC). Methods Data of 107 OC patients were retrospectively collected, and all patients completed CRS treatment and were followed up for 2 years. These patients were divided into recurrence group and non-recurrence group according to tumor recurrence within 2 years after surgery. Logistic regression analysis was used to investigate the influencing factors of postoperative recurrence of CRS in OC patients. Results Among 107 OC patients, 68 patients relapsed after CRS, with a recurrence rate of 63.55%. The expression of breast cancer susceptibility gene-1(BRCA-1), poly adenosine diphosphate ribose polymerase-1(PARP-1), residual tumor diameter, intraoperative lymph node dissection, carbohydrate antigen 125(CA125) level and human epididymal protein 4(HE4) level showed significant differences between the recurrence group and the non-recurrence group(P<0.05). Compared age, tumor diameter, International Federation of Gynecology and Obstetrics(FIGO) stage, disease type, histological type, delivery times, preoperative menopause, lymph node metastasis, proportion of tumor cells with different degrees of differentiation, serum CA199 and carcinoembryonic antigen(CEA) between recurrent and non-recurrent OC patients, there was no statistical significant difference(P>0.05). Logistic regression analysis showed that BRCA-1 positive expression, PARP-1 positive expression, residual tumor diameter >1 cm, unperformed intraoperative lymph node dissection, increased CA125 and HE4 levels might be the influencing factors of postoperative recurrence after CRS in OC patients(OR>1,P<0.05).Conclusion BRCA-1 positive expression, PARP-1 positive expression, residual tumor diameter >1 cm, intraoperative uncleaned lymph nodes, increased CA125 and HE4 levels may be the risk factors of postoperative recurrence after CRS in OC patients.
作者 陈燕荣 武明娟 刘冰 赵敏 CHEN Yanrong;WU Mingjuan;LIU Bing;ZHAO Min(Department of Gynecology,the 738th Sanatorium of China Aerospace Technology Group Company,Wuxi,Jiangsu,214000;Department of Gynecology,Wuxi Maternal and Child Health Care Hospital of Jiangsu Province,Wuxi,Jiangsu,214000;Department of Gynecology,Harbin First Hospital of Heilongjiang,Harbin,Heilongjiang,150010)
出处 《实用临床医药杂志》 CAS 2022年第15期103-108,共6页 Journal of Clinical Medicine in Practice
基金 江苏省第五期“333工程”科研项目资助(BRA2017105)。
关键词 卵巢癌 肿瘤细胞减灭术 糖类抗原125 乳腺癌易感基因-1 聚腺苷二磷酸核糖聚合酶-1 人附睾分泌蛋白4 ovarian cancer cytoreductive surgery carbohydrate antigen 125 breast cancer susceptibility gene-1 poly adenosine diphosphate ribose polymerase-1 human epididymal secretory protein 4
  • 相关文献

参考文献11

二级参考文献55

共引文献246

同被引文献50

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部